INHIBIKASE THERAPEUTICS INC (IKT) Stock Income Statement
USA - NASDAQ:IKT - US45719W2052 - Common Stock
1.53 USD
-0.07 (-4.38%)
1.5325 USD
+0 (+0.16%)
| TTM (2025-6-30) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| Revenue | 0 | 0 | 260.50K | 120.00K | 3.10M | |||
| Gross Premiums Earned | null | null | null | null | null | |||
| Loss Claims | null | null | null | null | null | |||
| Deferred Policy Acquisition Expense | null | null | null | null | null | |||
| Net Interest Income | null | null | null | null | null | |||
| Non Interest Income | null | null | null | null | null | |||
| Loan Loss Provision | null | null | null | null | null | |||
| Net Interest Income after Provision | null | null | null | null | null | |||
| Non Interest Expense | null | null | null | null | null | |||
| Minority Interest Expense | null | null | null | null | null | |||
| Cost Of Goods | null | null | null | null | null | |||
| Gross Profit | null | null | null | null | null | |||
| Operating Expenses | 44.19M | 28.59M | 20.35M | 18.25M | 17.87M | |||
| Research and Development | 27.17M | 17.21M | 13.62M | 12.03M | 11.36M | |||
| Selling, General, and Administrative Expenses | 18.54M | 11.38M | 6.73M | 6.22M | 6.51M | |||
| Operating Income | -44.19M | -28.59M | -20.09M | -18.13M | -14.77M | |||
| Interest Income/Expense | 2.68M | 1.07M | 1.06M | 70.00K | -20.00K | |||
| Other Income/Expense | null | null | null | null | null | |||
| Non Recurring Items | null | null | null | null | null | |||
| Income Before Taxes | -41.51M | -27.52M | -19.03M | -18.05M | -14.79M | |||
| Income Tax | null | null | null | null | null | |||
| Net Income | -41.51M | -27.52M | -19.03M | -18.05M | -14.79M | |||
| EBITDA | -44.14M | -28.56M | -19.91M | -18.12M | undefined | |||
| Per Share Data | ||||||||
| EPS Diluted Total Ops | -1.6656 | -1.1606 | -3.5681 | -4.3 | -3.53 | |||
| Non GAAP EPS | -1.4300000000000002 | -2.54 | -3.5700000000000003 | -4.32 | null | |||
| Statistics | ||||||||
| Profit Margin | N/A | N/A | -7304.76% | -15041.67% | -477.10% | |||
| Operating Profit Margin | N/A | N/A | -7712.02% | -15108.33% | -476.45% | |||
All data in USD